AeroVironment Books a Landmark Laser Win and Record Revenue — but the Stock Already Prices It In

AeroVironment just handed its shareholders a quarter most companies would brag about. It posted record revenue, built its order backlog to a record high, beat Wall Street's earnings estimate by more than a factor of two, and won a landmark U.S. Army contract to build the military's first production laser weapon. The stock popped for a day and then drifted right back to about $147 — down roughly 40% for the year and nearly two-thirds off its January high.

When a company's best news in years can't hold a rally, the market is telling you something. The question is whether it's telling you to buy the dip or to stay away.

The headline news is genuinely unusual. In late August the Army awarded AeroVironment a $464.8 million contract to produce its LOCUST X3 laser, the first directed-energy production deal in U.S. military history — a step that moves high-energy lasers from testing into battlefield production. On top of that came the company's first international LOCUST order, worth over $50 million, on the pitch that a single shot costs under $10, versus the tens of thousands of dollars for the drones it shoots down. Management frames it as a near-unlimited magazine against swarms of cheap enemy drones.

The numbers underneath were strong, too. Fiscal first-quarter revenue hit a record $480.5 million, up 6% from a year earlier and ahead of consensus. Adjusted earnings of $0.59 a share more than doubled the analyst estimate. Bookings of about $0.7 billion produced a 1.4x book-to-bill ratio, funded backlog rose 37% year over year to a record $1.5 billion, and total backlog hit $2.8 billion.

Here is the thing that should give a contrarian pause before he declares selling exhaustion and piles in: none of that is what broke the stock in the first place, and the damage came from identifiable events, not a vague narrative.

The selloff that started the year is traceable. In March, AeroVironment missed revenue badly — $408 million, roughly 14% below expectations — after a government funding delay pushed orders out and the U.S. Space Force terminated a satellite-communications contract, which triggered a $151 million goodwill impairment. Then in July, management outlined ambitious long-term targets at its investor day and RBC Capital downgraded the stock the next day, questioning whether AeroVironment could hit double-digit growth and expand margins at the same time in a flat defense budget. That downgrade was thesis-based, not price-based, and thesis-based downgrades carry information. And across this entire period, the company kept reaffirming its fiscal 2027 guidance rather than raising it — even now, after the laser wins.

That last point is the crux of the valuation question. Management reaffirmed its fiscal 2027 guidance of $2.125 billion to $2.225 billion in revenue and adjusted EPS of $3.02 to $3.34. Take the midpoint of that earnings range, roughly $3.18, and the stock at $147 trades at about 45 times this year's guided earnings. That is not a cheap stock, and it isn't cheap even after a 40% drawdown.

It is also worth understanding why a company posting "record revenue" reports GAAP losses at the same time. A large part of the gap is non-cash amortization tied to the BlueHalo acquisition and heavy spending to build out manufacturing for programs like LOCUST — the company has been free-cash-flow negative while it invests. That's normal during a build-out, but it means investors are being asked to pay a premium multiple for earnings that exist mostly on an adjusted basis and for a laser business whose revenue lands over multiple years, not all at once. The $465 million contract is spread across a multi-year ramp, which is exactly why "reaffirm rather than raise" was the safe move.

So is the valuation already full? Largely yes. The stock's decline has taken the multiple down from an extreme, but it has not made the company cheap on forward earnings. The price already encodes the laser success, the backlog, and the return to growth. What the market is skeptical about — rightly, so far — is whether the company actually delivers the back-half acceleration its own reaffirmed guidance implies, and whether margins improve as called for while capital spending stays heavy. AeroVironment's first-quarter revenue grew just 6%, a far slower pace than the roughly 10% the full-year guide assumes, so nearly all the work is still ahead.

That reframes the setup honestly. This isn't the clean contrarian case where price has run far ahead of intact fundamentals and the market has baked in doom; part of that doom was earned, by a real miss, a thesis-based downgrade, and slugged guidance. The laser win is a genuine moat-building milestone, and the backlog gives real visibility. But on a 45-times-forward-earnings basis, the market is not asking you to take risk for free — it's asking you to underwrite execution. The more disciplined stance is to let the company prove the reaffirmed guidance is too conservative before treating the stock as cheap. If the back half accelerates and margins expand, the multiple has room to work; if it delivers "in line" again, the full valuation is exactly what keeps compressing.